OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00209257

Xinjiang Zhongtai Chemical Co Ltd

Specialty ChemicalsVerified

Xinjiang Zhongtai Chemical Co Ltd has a debt-to-equity ratio of 1.84, indicating a relatively high level of leverage. The company's liquidity is assessed as medium, with a current ratio of 0.45, suggesting potential short-term liquidity constraints. Despite a net cash position of negative CNY 39.57 billion, the company reported operating cash flow of CNY 3.25 billion in the latest period. The company's profitability is under pressure, with a net loss of CNY 288.75 million and an operating loss of CNY 118.72 million. Return on equity is negative at -1.34%, and return on assets is also negative at -0.38%, both significantly below the industry median for specialty chemicals. Gross profit of CNY 526.96 million represents a margin of 18.36%, which is in line with the industry average but insufficient to offset operating costs. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financials. This lack of diversification increases exposure to regional economic and regulatory risks. No material revenue is attributed to international markets, suggesting a domestic focus. Looking ahead, the company is expected to face continued financial pressure, with no clear path to profitability in the near term. Capital expenditures of CNY 2.98 billion in the latest period indicate ongoing investment in operations, but free cash flow remains negative at CNY 56.96 million. The company's operating cash flow is the primary source of liquidity, but this may not be sufficient to service its long-term debt of CNY 39.57 billion. The company's risk profile is elevated due to its high leverage and negative net income. The risk assessment indicates a medium liquidity risk and a low dilution risk, with no immediate pressure for equity issuance. However, the negative net cash position and high debt load could lead to increased financial stress in the event of a downturn. Recent filings and disclosures show no material changes in the company's operations or risk profile. The ESG scores indicate moderate governance and social performance, with a controversies score of 100.00, suggesting no recent ESG-related incidents. No significant regulatory or legal issues were disclosed in the latest reports.

30-day price · 002092-1.91 (-27.5%)
Low$5.04High$7.10Close$5.04As of22 May, 00:00 UTC
Profile
CompanyXinjiang Zhongtai Chemical Co Ltd
Ticker002092.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Xinjiang Zhongtai Chemical Co Ltd is a specialty chemicals company that produces and sells chemical products, primarily serving industrial and manufacturing sectors.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry, with a classification confidence of 0.92.

Xinjiang Zhongtai Chemical Co Ltd has a debt-to-equity ratio of 1.84, indicating a relatively high level of leverage. The company's liquidity is assessed as medium, with a current ratio of 0.45, suggesting potential short-term liquidity constraints. Despite a net cash position of negative CNY 39.57 billion, the company reported operating cash flow of CNY 3.25 billion in the latest period. The company's profitability is under pressure, with a net loss of CNY 288.75 million and an operating loss of CNY 118.72 million. Return on equity is negative at -1.34%, and return on assets is also negative at -0.38%, both significantly below the industry median for specialty chemicals. Gross profit of CNY 526.96 million represents a margin of 18.36%, which is in line with the industry average but insufficient to offset operating costs. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financials. This lack of diversification increases exposure to regional economic and regulatory risks. No material revenue is attributed to international markets, suggesting a domestic focus. Looking ahead, the company is expected to face continued financial pressure, with no clear path to profitability in the near term. Capital expenditures of CNY 2.98 billion in the latest period indicate ongoing investment in operations, but free cash flow remains negative at CNY 56.96 million. The company's operating cash flow is the primary source of liquidity, but this may not be sufficient to service its long-term debt of CNY 39.57 billion. The company's risk profile is elevated due to its high leverage and negative net income. The risk assessment indicates a medium liquidity risk and a low dilution risk, with no immediate pressure for equity issuance. However, the negative net cash position and high debt load could lead to increased financial stress in the event of a downturn. Recent filings and disclosures show no material changes in the company's operations or risk profile. The ESG scores indicate moderate governance and social performance, with a controversies score of 100.00, suggesting no recent ESG-related incidents. No significant regulatory or legal issues were disclosed in the latest reports.
Key takeaways
  • The company is highly leveraged, with a debt-to-equity ratio of 1.84 and a negative net cash position.
  • Operating and net losses persist, with return on equity and return on assets both negative.
  • Revenue is concentrated in a single business segment, with no geographic diversification disclosed.
  • Capital expenditures are high, but free cash flow remains negative.
  • Liquidity is a concern, with a current ratio of 0.45 and no immediate dilution pressure.
  • ESG performance is moderate, with no recent controversies reported.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$28.70B
Gross profit$5.27B
Operating income-$118.7M
Net income-$288.8M
R&D
SG&A
D&A
SBC
Operating cash flow$3.25B
CapEx-$2.98B
Free cash flow-$569.6M
Total assets$76.79B
Total liabilities$55.27B
Total equity$21.52B
Cash & equivalents
Long-term debt$39.57B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$21.52B
Net cash-$39.57B
Current ratio0.5
Debt/Equity1.8
ROA-0.4%
ROE-1.3%
Cash conversion-11.2%
CapEx/Revenue-10.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric002092Activity
Op margin-0.4%0.4% medp25 -8.0% · p75 16.0%below median
Net margin-1.0%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin18.4%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-10.4%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity184.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Social pillar45.19 (0-100)
Governance pillar47.93 (0-100)
ESG controversies score100.00 (0-100, higher = fewer controversies)
Source: analysis-pipeline (hybrid)Generated: 2026-05-19 22:42 UTCJob: 6d6f5f5d